Acorda Therapeutics
ACOR
#10025
Rank
ยฃ0.63 M
Marketcap
ยฃ0.51
Share price
0.00%
Change (1 day)
-95.88%
Change (1 year)

Revenue for Acorda Therapeutics (ACOR)

Revenue in 2024 (TTM): ยฃ92.13 Million

According to Acorda Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ89.52 Million. In 2023 the company made a revenue of ยฃ92.33 Million a decrease over the revenue in the year 2022 that were of ยฃ98 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acorda Therapeutics from 2006 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ92.13 M-0.22%
2023 ยฃ92.33 M-5.79%
2022 ยฃ98 M2.5%
2021 ยฃ95.61 M-14.8%
2020 ยฃ0.11 B-23.52%
2019 ยฃ0.14 B-60.49%
2018 ยฃ0.37 B-14.68%
2017 ยฃ0.43 B3.37%
2016 ยฃ0.42 B26.67%
2015 ยฃ0.33 B28.92%
2014 ยฃ0.25 B26.43%
2013 ยฃ0.20 B7.8%
2012 ยฃ0.18 B0.63%
2011 ยฃ0.18 B51.96%
2010 ยฃ0.12 B266.21%
2009 ยฃ33.78 M3.54%
2008 ยฃ32.63 M64.18%
2007 ยฃ19.87 M42.34%
2006 ยฃ13.96 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ0.46 B 420.78%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.00 B 2,137.86%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.21 M-97.52%๐Ÿ‡ฉ๐Ÿ‡ช Germany
ยฃ1.16 B 1,201.18%๐Ÿ‡บ๐Ÿ‡ธ USA